Image of Abiomed Breethe OXY-1 System™ on navy background with hash pattern overlay

Abiomed Breethe OXY-1 System™

Cardiopulmonary Support System


The OXY-1 System is the novel, easy-to-use, compact cardiopulmonary support system, with an integrated oxygen concentrator and pump that provides an independent oxygen source to support transition from bed to ambulation via system portability. The OXY-1 System pumps, oxygenates and removes carbon dioxide from blood.

Oxygenator Performance

Image of Abiomed Breethe OXY-1 System™ on navy background with hash pattern overlay

The OXY-1 System is designed with an advanced gas exchange technology, including an innovative oxygen concentrator that provides full patient support with reduced O2 demand.


Pump Driver Unit
Disposable PLU

Additional Resources

Abiomed Breethe OXY-1 System instructions for use and reference manual

Download PDF

Learn more about the features of the Abiomed Breethe OXY-1 System™.

Download PDF

Abiomed Breethe OXY-1 System Device Indication & Safety Information

Indications for Use

The OXY-1 System is intended to be used for extracorporeal circulation. The OXY-1 System pumps, oxygenates and removes carbon dioxide from blood during cardiopulmonary bypass up to 6 hours in duration.

Intended Users

The OXY-1 System must be operated and/or monitored by users with specialized training in extracorporeal circulation therapy. These users include perfusionists, extracorporeal circulation specialists, ICU nurses with specialized extracorporeal circulation training, cardiothoracic surgeons, intensivists, and others with specialized training and experience. Users are required to be knowledgeable and experienced in methods that require cardiopulmonary bypass and mechanical circulatory support.

Utilization of the Abiomed Breethe OXY-1 System requires clinical judgment for patient risks vs benefits in all circumstances and requires specialized training in the use of cardiopulmonary bypass systems for safe operation under the direct supervision of a qualified physician. This is a prescription-only device.

Important Risk Information


This device used for any other purposes than for the indicated intended use is the responsibility of the user.

In addition to the risks above, there are other WARNINGS and PRECAUTIONS associated with the Abiomed Breethe OXY-1 System.


Under guidance issued by FDA, on April 6, 2020, the Abiomed Breethe OXY-1 System is now permitted to be used temporarily in the U.S. for ECMO therapy greater than six hours. Therefore, it now has a limited indication modification for use longer than six hours in an extracorporeal membrane oxygenation (ECMO) circuit to treat patients who are experiencing acute temporary respiratory or acute cardiopulmonary failure. This limited indication modification for ECMO therapy greater than six hours has not been cleared or approved by FDA and is in effect only for the duration of the public health emergency related to COVID-19 as declared by the U.S. Department of Health and Human Services (HHS).


This information is intended for use by customers, patients, and healthcare professionals in [region] only. We recognize that the Internet is a global communications medium; however, laws, regulatory requirements, and product information for medical products can vary from country to country. The product information included here may not be appropriate for use outside [region], and the information from other sites you visit may not be appropriate for use in [region].